Posted on June 15, 2022 by Hokkaido NewsHOPS-R01 phase II trial evaluating neoadjuvant S-1 therapy for resectable pancreatic adenocarcinoma | Scientific Reports – Nature.com HOPS-R01 phase II trial evaluating neoadjuvant S-1 therapy for resectable pancreatic adenocarcinoma | Scientific Reports Nature.com
